Preventive and Therapeutic Effect of Aidi Injection on Radiation-Induced Lung Injury

Jian-xu LI,Ya-mei ZHENG,Xiao-yan HU,Kai TENG,Ru-bo CAO,Li LIU

DOI: https://doi.org/10.3870/yydb.2014.02.013

2014-01-01

Abstract:Objective To study the effect of aidi injection on radiation-induced lung injury and the probable Mechanism. Methods One hundred and twenty C57BL /6 mice were exposed to either sham radiation or single fraction of 12 Gy delivered to the thorax. Four groups were defined as follows: in normal control group,the mice received neither radiation nor drug; in aidi injection + radiation group,the mice received radiation and aidi injection; in Solu Medrol + radiation group,the mice received Solu Medrol; in radiation group,the mice were exposed to radiation. Aidi or Solu Medrol were injected intraperitoneally 2 h before the radiation and daily after the radiation. Mice were sacrificed 1,24,72 hours,1,2,4,8,16 and 24 weeks after radiation. The left lungs were fixed and sectioned. The sections were stained by haematoxylin and eosin,masson stain and immunohistochemical stain for transforming growth factor β1( TGF-β1). The right lungs were collected to detect TGF-β1mRNA expression by real-time quantitative reverse transcipiase polymerase chain reaction( RT-PCR) and TGF-β1protein expression by Western blotting. Results Pneumonitis developed 1 to 2 weeks after radiation. Their TGF-β1mRNA and protein expression levels in radiation-treated mice were significantly higher than those in normal control group( both P 0. 05). But the effects were reversed by aidi and Solu Medrol treatment( P 0. 05). The TGF-β1mRNA and protein expression levels were not significantly different between aidi and Solu Medrol treatment. Conclusion Both aidi injection and Solu Medrol can significantly downregulate TGF-β1mRNA and protein expression levels in the lungs of mice with radiation-induced lung injury. There is no significant difference in the effect between aidi injection and Solu Medrol.